Eledon Pharmaceuticals (ELDN) Institutional Ownership $5.30 +0.65 (+13.98%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Eledon Pharmaceuticals (NASDAQ:ELDN)CurrentInstitutional OwnershipPercentage56.77%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$3.20MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$25.76K Get ELDN Insider Trade Alerts Want to know when executives and insiders are buying or selling Eledon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELDN Institutional Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Eledon Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/30/2024 Clarity Capital Partners LLC11,500$29K0.0%N/A0.029% 8/20/2024Nantahala Capital Management LLC600,000$1.58M0.1%N/A2.418% 8/15/2024Armistice Capital LLC2,336,000$6.17M0.1%+1.7%9.414% 8/9/2024Renaissance Technologies LLC136,773$361K0.0%+57.1%0.551% 8/9/2024Dimensional Fund Advisors LP30,233$80K0.0%N/A0.122% 8/8/2024Marco Investment Management LLC30,344$80K0.0%+22.3%0.122% Get the Latest News and Ratings for ELDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/14/2024CM Management LLC160,000$330K0.3%+14.3%0.645% 5/10/2024Vanguard Group Inc.969,121$2.00M0.0%+39.4%3.906% 2/13/2024Armistice Capital LLC2,189,000$3.94M0.1%+20.0%9.045% 11/15/2023Armistice Capital LLC1,824,000$2.50M0.0%-1.0%7.538% 10/19/2023 Jmac Enterprises LLC58,041$80K0.0%-27.5%0.246% 8/15/2023BVF Inc. IL4,326,710$5.93M0.2%+86.0%18.372% 8/11/2023SVB Financial Group18,025$25K0.0%-33.1%0.080% 7/20/2023 Jmac Enterprises LLC80,041$110K0.0%+46.8%0.356% 2/9/2023CM Management LLC234,800$535K0.6%-4.2%1.706% 11/14/2022Cormorant Asset Management LP1,223,500$3.38M0.2%-6.3%8.894% 11/14/2022Point72 Asset Management L.P.375,000$1.04M0.0%-12.5%2.726% 11/14/2022Boothbay Fund Management LLC22,050$61K0.0%-36.3%0.160% 11/4/2022CM Management LLC245,000$676K0.8%+8.9%1.781% 8/16/2022Woodline Partners LP516,675$1.26M0.0%-23.2%3.755% 5/9/2022CM Management LLC225,000$887K0.7%+95.7%1.636% 4/25/2022 Bailard Inc.27,600$109K0.0%N/A0.193% 2/14/2022Point72 Asset Management L.P.431,435$1.90M0.0%+105.9%3.016% 2/11/2022Ensign Peak Advisors Inc77,100$340K0.0%+966.7%0.539% 2/7/2022 Ameritas Advisory Services LLC24,219$107K0.0%N/A0.169% 2/2/2022CM Management LLC115,000$507K0.4%+53.3%0.804% 11/16/2021Two Sigma Advisers LP115,900$716K0.0%+48.0%0.810% 11/16/2021Two Sigma Investments LP115,324$713K0.0%+100.5%0.806% 11/16/2021BVF Inc. IL1,363,435$8.43M0.3%+22.5%9.530% 11/15/2021Point72 Asset Management L.P.209,490$1.30M0.0%+11.0%1.464% 11/15/2021Eversept Partners LP114,008$705K0.1%N/A0.797% 11/15/2021Ensign Peak Advisors Inc7,228$45K0.0%-80.0%0.051% 11/10/2021Mercer Global Advisors Inc. ADV16,726$103K0.0%N/A0.117% 8/18/2021Ikarian Capital LLC350,000$2.77M0.2%+40.0%2.446% 8/17/2021Woodline Partners LP857,445$6.78M0.1%-3.8%5.993% 8/17/2021Boothbay Fund Management LLC40,052$317K0.0%+39.6%0.280% 8/16/2021Point72 Asset Management L.P.188,690$1.49M0.0%+51.0%1.319% 8/16/2021Morgan Stanley851,004$6.73M0.0%+7,235.6%5.948% 8/16/2021State Street Corp32,935$261K0.0%N/A0.230% 8/13/2021Renaissance Technologies LLC21,107$167K0.0%-22.0%0.148% 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here8/13/2021Northern Trust Corp32,116$254K0.0%+106.8%0.224% 8/13/2021Geode Capital Management LLC124,614$985K0.0%+25.7%0.871% 8/13/2021Vanguard Group Inc.209,750$1.66M0.0%-8.8%1.466% 5/19/2021Logos Global Management LP224,071$2.40M0.2%N/A1.566% 5/18/2021BVF Inc. IL1,113,435$11.91M0.4%N/A7.782% 5/18/2021Millennium Management LLC14,588$156K0.0%N/A0.102% 5/18/2021Point72 Asset Management L.P.125,000$1.34M0.0%N/A0.874% 5/18/2021Cormorant Asset Management LP1,415,500$15.15M0.3%N/A9.894% 5/18/2021Citadel Advisors LLC25,062$268K0.0%N/A0.175% 5/17/2021Woodline Partners LP891,055$9.53M0.2%N/A6.228% 5/17/2021EcoR1 Capital LLC1,115,721$11.94M0.5%N/A7.798% 5/17/2021Janus Henderson Group PLC213,899$2.25M0.0%N/A1.495% 5/17/2021Ikarian Capital LLC250,000$2.68M0.1%N/A1.747% 5/13/2021Renaissance Technologies LLC27,051$289K0.0%N/A0.189% 5/12/2021Northern Trust Corp15,528$166K0.0%N/A0.109% 5/12/2021Geode Capital Management LLC99,123$1.06M0.0%N/A0.693% 5/12/2021CM Management LLC75,000$803K0.6%N/A0.524% 5/7/2021BlackRock Inc.12,282$131K0.0%N/A0.086% 4/21/2021Ingalls & Snyder LLC51,149$547K0.0%N/A0.358% (Data available from 1/1/2016 forward) ELDN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELDN shares? During the previous two years, 14 institutional investors and hedge funds held shares of Eledon Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($6.17M), BVF Inc. IL ($5.93M), Cormorant Asset Management LP ($3.38M), Vanguard Group Inc. ($2.00M), Nantahala Capital Management LLC ($1.58M), Point72 Asset Management L.P. ($1.04M), and Renaissance Technologies LLC ($361K).Learn more on ELDN's institutional investors. What percentage of Eledon Pharmaceuticals stock is owned by institutional investors? 56.77% of Eledon Pharmaceuticals stock is owned by institutional investors. Learn more on ELDN's institutional investor holdings. Which institutional investors have been buying Eledon Pharmaceuticals stock? Of the 10 institutional investors that purchased Eledon Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2M), Nantahala Capital Management LLC ($600K), Armistice Capital LLC ($404K), Vanguard Group Inc. ($273.70K), Renaissance Technologies LLC ($49.70K), CM Management LLC ($40K), and Dimensional Fund Advisors LP ($30.23K). How much institutional buying is happening at Eledon Pharmaceuticals? Institutional investors have bought a total of 3,440,178 shares in the last 24 months. This purchase volume represents approximately $6.03M in transactions. Which Eledon Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Eledon Pharmaceuticals stock in the last 24 months: Cormorant Asset Management LP ($81.60K), Point72 Asset Management L.P. ($53.36K), Jmac Enterprises LLC ($22K), Armistice Capital LLC ($18.80K), Boothbay Fund Management LLC ($12.58K), CM Management LLC ($10.20K), and SVB Financial Group ($8.92K). How much institutional selling is happening at Eledon Pharmaceuticals? Institutional investors have sold a total of 207,455 shares in the last 24 months. This volume of shares sold represents approximately $498.57K in transactions. Related Companies DNTH Institutional Ownership SANA Institutional Ownership REPL Institutional Ownership CRON Institutional Ownership RLAY Institutional Ownership ANNX Institutional Ownership ERAS Institutional Ownership ABUS Institutional Ownership OCS Institutional Ownership IMNM Institutional Ownership This page (NASDAQ:ELDN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eledon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eledon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
